These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 19295242
1. Aspirin-induced COX-2 overexpression in monocytes of aspirin-intolerant patients. Morgan T, Bajrovic N, Silar M, Kosnik M, Korosec P. Int Arch Allergy Immunol; 2009; 149(4):378-84. PubMed ID: 19295242 [Abstract] [Full Text] [Related]
2. Deficiency of cyclooxygenases transcripts in cultured primary bronchial epithelial cells of aspirin-sensitive asthmatics. Pierzchalska M, Soja J, Woś M, Szabó Z, Nizankowska-Mogielnicka E, Sanak M, Szczeklik A. J Physiol Pharmacol; 2007 Jun; 58(2):207-18. PubMed ID: 17622692 [Abstract] [Full Text] [Related]
3. Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release. Kowalski ML, Borowiec M, Kurowski M, Pawliczak R. Allergy; 2007 Jun; 62(6):628-34. PubMed ID: 17508966 [Abstract] [Full Text] [Related]
4. Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma. Pujols L, Mullol J, Alobid I, Roca-Ferrer J, Xaubet A, Picado C. J Allergy Clin Immunol; 2004 Oct; 114(4):814-9. PubMed ID: 15480320 [Abstract] [Full Text] [Related]
5. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. Mastalerz L, Sanak M, Gawlewicz-Mroczka A, Gielicz A, Cmiel A, Szczeklik A. Thorax; 2008 Jan; 63(1):27-34. PubMed ID: 17584993 [Abstract] [Full Text] [Related]
6. Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma. Gaber F, Daham K, Higashi A, Higashi N, Gülich A, Delin I, James A, Skedinger M, Gyllfors P, Nord M, Dahlén SE, Kumlin M, Dahlén B. Thorax; 2008 Dec; 63(12):1076-82. PubMed ID: 18757457 [Abstract] [Full Text] [Related]
7. Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge. Mita H, Higashi N, Taniguchi M, Higashi A, Akiyama K. Clin Exp Allergy; 2004 Aug; 34(8):1262-9. PubMed ID: 15298568 [Abstract] [Full Text] [Related]
8. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease. Sciulli MG, Renda G, Capone ML, Tacconelli S, Ricciotti E, Manarini S, Evangelista V, Rebuzzi A, Patrignani P. Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573 [Abstract] [Full Text] [Related]
9. Altered monocyte cyclooxygenase response to lipopolysaccharide in type 1 diabetes. Beyan H, Goodier MR, Nawroly NS, Hawa MI, Bustin SA, Ogunkolade WB, Londei M, Yousaf N, Leslie RD. Diabetes; 2006 Dec; 55(12):3439-45. PubMed ID: 17130490 [Abstract] [Full Text] [Related]
10. Expression of cyclooxygenase and lipoxygenase enzymes in nasal polyps of aspirin-sensitive and aspirin-tolerant patients. Owens JM, Shroyer KR, Kingdom TT. Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):579-87. PubMed ID: 16785401 [Abstract] [Full Text] [Related]
11. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases. Fraj J, Valero A, Vives R, Pérez I, Borja J, Izquierdo I, Picado C. Allergy; 2008 Jan; 63(1):112-5. PubMed ID: 18053020 [Abstract] [Full Text] [Related]
12. Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma. Adamjee J, Suh YJ, Park HS, Choi JH, Penrose JF, Lam BK, Austen KF, Cazaly AM, Wilson SJ, Sampson AP. J Pathol; 2006 Jul; 209(3):392-9. PubMed ID: 16583357 [Abstract] [Full Text] [Related]
13. Management options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivity. Knowles SR, Drucker AM, Weber EA, Shear NH. Ann Pharmacother; 2007 Jul; 41(7):1191-200. PubMed ID: 17609236 [Abstract] [Full Text] [Related]
14. Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients. Fuentes-Beltrán A, Montes-Vizuet R, Valencia-Maqueda E, Negrete-García MC, García-Cruz Mde L, Teran LM. Clin Exp Allergy; 2009 Apr; 39(4):491-9. PubMed ID: 19226274 [Abstract] [Full Text] [Related]
15. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics. Micheletto C, Tognella S, Visconti M, Trevisan F, Dal Negro RW. Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396 [Abstract] [Full Text] [Related]
19. Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: Possible role in therapeutic benefit associated with aspirin desensitization. Steinke JW, Culp JA, Kropf E, Borish L. J Allergy Clin Immunol; 2009 Oct; 124(4):724-30.e4. PubMed ID: 19767084 [Abstract] [Full Text] [Related]
20. [Asthma with hypersensitivity to aspirin]. Nizankowska-Mogilnicka E. Pol Merkur Lekarski; 2003 Jun; 14(84):561-5. PubMed ID: 14524272 [Abstract] [Full Text] [Related] Page: [Next] [New Search]